Search for Clinical Trial Results
Blastic Plasmacytoid Dendritic Cell - 11 Studies Found
Status | Study |
Active, not recruiting |
Study Name: An Open-label Phase II Study of Lorvotuzumab Mertansine Condition: Leukemia Date: 2015-04-15 Interventions: Drug: Lorvotuzumab Mertansine (IMGN901) 100 mg/m2 by vein on Day 1 and 8 of a 21-day cycle. |